Compliance · State rules

Office-use compounding in Vermont

No human non-patient-specific limb; veterinary office use expressly permitted, including resale

USPeptideRx EditorialLast reviewed: August 30, 2026

Vermont’s compounding rule lists the three ways compounding may be performed, and the list is closed. Two of the three run to a specific patient. The third is veterinary, and it is unusually generous — it permits compounding for veterinary use including resale by veterinary clinics, which is a step further than most veterinary limbs in this file go. There is no human non-patient-specific limb anywhere in it. A separate sentence in the same rule says 503B outsourcers are not required to register as compounding pharmacies, which is Vermont acknowledging the other channel rather than closing it. One warning for anyone checking this themselves: Vermont replaced its entire pharmacy ruleset on 1 February 2026 and the old decimal rule numbers are dead.

The governing rule

Vermont’s office-use position is set by Vermont Board of Pharmacy Administrative Rules, Rule 10-4(c) (effective 2026-02-01). The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

Vermont Board of Pharmacy Rule 10-4(c) — the closed three-limb grant

Requirements. Compounding must be performed: (1) pursuant to a practitioner’s patient-specific order based on the practitioner-patient-pharmacist-compounder relationship; (2) in limited quantities and for a specific patient, based on a history of routine, regularly observed prescribing patterns; or (3) for veterinary use, including resale by veterinary clinics.

Vermont Board of Pharmacy Rule 10-4(a) — the other channel, named

503B Outsourcers are not required to register as compounding pharmacies.

Vermont Board of Pharmacy Rule 10-4(b) — where the standards come from

Compliance. A compounding pharmacy must comply with all applicable law and USP chapters, including 21 U.S.C. § 353a, USP <795> for non-sterile compounding, USP <797> for sterile compounding, and USP <800> for compounding of hazardous drugs.

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The list is closed, and that is what decides itHigh confidence: Rule 10-4(c) says compounding must be performed in one of three ways. Two are patient-specific, including the anticipatory limb, which is expressly tied to a specific patient and a history of regular prescribing. The third is veterinary. Human non-patient-specific compounding is not among them, so a human office-stock order does not fall inside any limb of the grant.
The veterinary limb goes further than mostHigh confidence: Vermont permits compounding for veterinary use "including resale by veterinary clinics". Most veterinary office-use limbs in this file stop at administration and expressly forbid resale; Vermont’s says the opposite in the same clause. If you are comparing states, do not carry the usual assumption across.
The 503B route is acknowledged in the same ruleHigh confidence: The rule states that 503B outsourcers are not required to register as compounding pharmacies. That is a registration carve-out rather than a supply permission, but it places the outsourcing facility outside the compounding-pharmacy scheme whose limbs close the human office-stock route — which is why a flat ban sentence is the wrong description of this state.
A federal hook, but only in one subsectionHigh confidence: The compliance subsection requires a compounding pharmacy to comply with applicable law and the USP chapters, and names 21 U.S.C. § 353a directly. The requirements subsection that closes the human route carries no federal hook of its own. The two are adjacent and do different work.
No sterility split and no labelling rule at allHigh confidence: The three-limb grant draws no line between sterile and non-sterile preparations, so there is no separate sterile route to look for. The 2026 ruleset also contains no compounded-drug labelling rule, which is a gap rather than a permission.
Cite the current numbering — the old one is dead and Vermont is still using itHigh confidence: Vermont replaced its whole Board of Pharmacy ruleset effective 1 February 2026, and the numbering changed from decimals to a Part-and-section form. Older decimal citations no longer point at anything. The trap is that Vermont’s own currently-linked board documents still cite the dead numbers, so copying a citation from an official Vermont source can hand you a reference that does not resolve.There is a second trap in the same area. The board’s stable, undated PDF of the rules was overwritten in place with the 2026 text, so anyone who bookmarked it before February 2026 now serves readers different law than they quoted, with nothing visible to signal the change. This page cites the dated file instead.

Vermont at a glance

Vermont office-use compounding summary, reviewed 2026-08-30
Human office use	Outside the closed three-limb grant; outsourcing facilities excepted by name
Sterile preparations	No split — the grant draws no sterility line
Quantity cap	Qualitative — "in limited quantities and for a specific patient"
Mandatory label legend	None — the ruleset carries no compounded-drug labelling rule
Board reporting	None for office use
Last change	Entire ruleset replaced, effective 1 February 2026
Governing rule	Vermont Board of Pharmacy Administrative Rules, Rule 10-4(c) (effective 2026-02-01)

Receiving 503B office stock in Vermont

Vermont is the first state in this file to regulate pharmacy through an office inside the Secretary of State, and it has a dedicated statutory licence class for outsourcing. The controlled-substance side carries a live duty with no published way to satisfy it, which is worth knowing before anyone promises a compliance route.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Vermont asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence: An Outsourcing licence. Vermont’s drug-outlet statute lists licence classifications and outsourcing is one of them in its own right, so this is a dedicated category rather than a manufacturer or wholesaler licence doing double duty. Licensing runs through the Office of Professional Regulation, which sits inside the Secretary of State’s office rather than a health department.
Does your practice need a permit?Medium confidence: For controlled substances, yes — and this is the part to read twice. Vermont law requires a certificate of approval for holding controlled stock, tied to the address and to the drug type, renewed annually and displayed. The duty is real and was amended recently. What we could not find anywhere is an application, a form, a fee page or any guidance for obtaining it.Report both halves together or the sentence misleads in one direction or the other. Saying Vermont requires nothing is wrong; saying there is a straightforward application to file is also wrong. Anyone in this position should contact the state rather than work from published material, because the published material does not appear to exist.
Administer vs dispenseHigh confidence: The distinction does not open a human office-stock route, because the bar operates on the compounding rather than on what the practice does afterwards. On the veterinary limb Vermont goes the other way and expressly contemplates resale by the clinic.
Scheduled (controlled) stockMedium confidence: Vermont does not issue a separate practitioner drug registration — the professional licence itself carries that authority for a natural person. Entities holding controlled stock are caught instead by the address-specific certificate of approval described above. So the qualifying concept differs depending on whether the holder is a person or an entity.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Federal law is a second, independent constraint — a state prohibition is not the only thing standing in the way. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how Vermont compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

The most important open item on this page is what Vermont’s rules said BEFORE the February 2026 replacement. The previous text could not be recovered — the board’s portal carries no attachment for it, the stable file was overwritten in place, and archived copies were unreachable. If the old ruleset contained a human office-use permission, then what is described here as an absence would instead be a repeal, which is a materially different and more citable finding.
Vermont law requires a certificate of approval for entities holding controlled stock, and no application, form, fee schedule or guidance for it appears to be published anywhere. We are reporting the duty and the missing route together, because either alone gives a false impression. If the state publishes a route, a currently dormant obligation becomes an operational one immediately.
The rule text on this page was read from the board’s dated file for the ruleset effective 1 February 2026. We are not publishing a Code of Vermont Rules citation for it, because no state-hosted source prints one for these rules and we will not invent a citation format we cannot verify.
Vermont’s own board guidance in this area is advisory rather than binding, uses "should" rather than "shall", and cites the superseded rule numbering. This page cites the rule itself instead.
We searched no case law, attorney-general opinions or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.